Inhibition of p53 degradation by Mdm2 acetylation

Xinjiang Wang1, Jan Taplick, Naama Geva

  • 1Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel.

FEBS Letters
|March 12, 2004
PubMed

Insights

Mdm2, a protein that degrades p53, is itself acetylated by CBP and p300. This acetylation, particularly in the RING finger domain, impairs Mdm2

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Mdm2 (mouse double minute 2 homolog) is a RING finger E3 ubiquitin ligase.
  • Mdm2 targets the p53 tumor suppressor protein for ubiquitination and proteasomal degradation.
  • Acetylation of p53 influences its transcriptional activity and inhibits Mdm2-mediated degradation.

Purpose of the Study:

  • To investigate whether Mdm2 is also a target of acetylation.
  • To determine the functional consequences of Mdm2 acetylation on p53 regulation.

Main Methods:

  • In vitro acetylation assays using purified proteins and cell extracts.
  • Identification of acetylation sites and domains within Mdm2.
  • In vivo acetylation studies in cells.
  • Analysis of Mdm2 activity using a mutant mimicking acetylation (K466/467Q).

Main Results:

  • Mdm2 is acetylated in vitro by CREB-binding protein (CBP) and p300, primarily in the RING finger domain.
  • In vivo acetylation of Mdm2 is efficiently mediated by CBP and requires an intact RING finger.
  • An Mdm2 mutant mimicking acetylation (K466/467Q) shows impaired p53 ubiquitination, Mdm2 autoubiquitination, and p53 degradation.

Conclusions:

  • Mdm2 is a novel target for acetylation by CBP and p300.
  • Acetylation of Mdm2, particularly within the RING finger domain, inactivates its E3 ligase activity.
  • Acetyltransferases can modulate cellular p53 activity by directly acetylating and inactivating Mdm2, in addition to acetylating p53.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.